{"id":1930,"date":"2019-09-27T17:56:02","date_gmt":"2019-09-27T15:56:02","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=1930"},"modified":"2024-12-13T13:49:24","modified_gmt":"2024-12-13T12:49:24","slug":"cancer-ginecologic","status":"publish","type":"page","link":"https:\/\/idibell.cat\/recerca\/area-de-cancer\/programa-de-mecanismes-moleculars-i-terapia-experimental-en-oncologia-oncobell\/cancer-ginecologic\/","title":{"rendered":"C\u00e0ncer Ginecol\u00f2gic"},"content":{"rendered":"\n

\n\t\tC\u00e0ncer ginecol\u00f2gic\n\t<\/h1>\n

\n\t\tResum\n\t<\/h3>\n\t

El grup de C\u00e0ncer ginecol\u00f2gic \u00e9s un equip multidisciplinari format per ginec\u00f2legs, onc\u00f2legs, pat\u00f2legs i investigadors b\u00e0sics. El grup compta amb tres l\u00edders, Xavier Matias-Guiu, tamb\u00e9 l\u00edder del grup CIBER (CB16 \/ 12\/00231, conjuntament amb IRBLLEIDA), Jordi Ponce, Mireia Martin-Satu\u00e9, David Llobet i Ruth Rodriguez-Barrueco. El grup acaba d’iniciar el treball col\u00b7laboratiu en diferents \u00e0rees del c\u00e0ncer ginecol\u00f2gic.<\/p>\n

 <\/p>\n

867<\/h2>\n

Publicacions<\/h2>\n\t\t\t\t\"mucinous_lmp_ovarian_tumour_intermed_mag\"\n\t\t\t\t\tL\u00ednies estrat\u00e8giques<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\tOncologia ginecol\u00f2gica cl\u00ednica i quir\u00fargica
\nSenyalitzaci\u00f3 purin\u00e8rgica en c\u00e8l\u00b7lules endometrials normals, endometriosi i c\u00e0ncer d’endometri
\nTractaments selectius i immunoter\u00e0pia en c\u00e0ncer ginecol\u00f2gic\n\t\t\t\t\t
Publicacions seleccionades<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t